Clinical Trial Update: A Phase 1 Study to Investigate the Mechanism of Action of Ipragliflozin [Phase 1]

View source ↗

Summary

A Phase 1 trial investigating the mechanism of action of ipragliflozin in Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• ipragliflozin (ipragliflozin)

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED